Obsessive–compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function
Article first published online: 26 FEB 2014
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Acta Psychiatrica Scandinavica
Volume 130, Issue 3, pages 214–226, September 2014
How to Cite
Obsessive–compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function., , , , , , , , , , , , , , , , , , , , , , , , , .
- Issue published online: 18 AUG 2014
- Article first published online: 26 FEB 2014
- Manuscript Accepted: 28 JAN 2014
- ERAB (European Research Advisory Board)
- Pfizer Pharma
- Roche Pharma
- I3G and AOK (health insurance company)
- University of Goettingen
- LMU Munich
- Janssen Cilag
- Otsuka Pharma
- German Research Foundation
- Servier, Pfizer Pharma GmbH
- Bristol-Myers Squibb GmbH & CoKGaA
- Evangelisches Studienwerk
- Landesgraduiertenförderung of the Heidelberg University
- Janssen Cilag
- at-risk mental state;
- obsessive–compulsive disorder;
Obsessive–compulsive symptoms (OCS) constitute a major comorbidity in schizophrenia. Prevalence estimations of OCS for patients with at-risk mental states (ARMS) for psychosis vary largely. It is unclear how ARMS patients with or without comorbid OCS differ regarding general psychosocial functioning, psychotic and affective symptoms and neurocognitive abilities.
At-risk mental states patients (n = 233) from the interventional trial PREVENT (Secondary Prevention of Schizophrenia) were stratified according to the presence or absence of comorbid OCS and compared on several clinical variables.
Patients, who fulfilled the criteria for obsessive–compulsive disorder (OCD) or presented with subclinical OCS (ARMSposOCS sample), did not significantly differ from patients without OCS (ARMSnegOCS) with regard to gender, age, premorbid verbal intelligence and levels of education. Furthermore, similar severity of depressive syndromes, basic cognitive, attenuated psychotic and brief limited intermittent psychotic symptoms were found. However, ARMSposOCS patients showed more impairment of psychosocial functioning and higher general psychopathology. In contrast, they scored higher in cognitive tasks measuring working memory and immediate verbal memory.
Findings extend upon previous results due to the multidimensional assessment. Subsequent longitudinal studies might elucidate how comorbid OCS influence differential treatment response, especially to cognitive behavioural interventions and the transition rates to psychosis.